Principal Investigator
Maria Carpintero
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20230562
Clinical Trial Summary
BMS-A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE)
(POETYK SLE-1)
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu